These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26490811)

  • 1. Insulin degludec products approved for diabetes.
    Traynor K
    Am J Health Syst Pharm; 2015 Nov; 72(21):1834. PubMed ID: 26490811
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin degludec (Tresiba)--a new long-acting insulin for diabetes.
    Med Lett Drugs Ther; 2015 Dec; 57(1483):163-4. PubMed ID: 26633683
    [No Abstract]   [Full Text] [Related]  

  • 3. Degludec, a new ultra-long-acting basal insulin for the treatment of diabetes mellitus type 1 and 2: advances in clinical research.
    Muñoz Torres M
    Endocrinol Nutr; 2014 Mar; 61(3):153-9. PubMed ID: 23890782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetes mellitus type 1 and 2. Flexible therapy with insulin degludec].
    Rausch R
    Med Monatsschr Pharm; 2014 Jul; 37(7):273-4. PubMed ID: 25065174
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating to target in type 2 diabetes: the BEGIN trial programme.
    Wangnoo SK; Chowdhury S; Rao PV
    J Assoc Physicians India; 2014 Jan; 62(1 Suppl):21-6. PubMed ID: 25330628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin degludec, a long-acting once-daily basal analogue for type 1 and type 2 diabetes mellitus.
    Berard L; MacNeill G
    Can J Diabetes; 2015 Feb; 39(1):4-9. PubMed ID: 25065475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review of the Clinical Efficacy and Safety of Insulin Degludec and Glargine 300 U/mL in the Treatment of Diabetes Mellitus.
    Woo VC
    Clin Ther; 2017 Aug; 39(8S2):S12-S33. PubMed ID: 28187863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Evolutionary Perspective on Basal Insulin in Diabetes Treatment: Innovations in Insulin: Insulin Degludec U-100 and U-200.
    Philis-Tsimikas A
    J Fam Pract; 2016 Oct; 65(10 Suppl):S14-S22. PubMed ID: 27846338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting insulin before surgery - which dose?
    Hall GM
    J Clin Anesth; 2012 Dec; 24(8):607-9. PubMed ID: 23228868
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal-bolus therapy in type 1 and type 2 diabetes.
    Kerlan V; Gouet D; Marre M; Renard É
    Ann Endocrinol (Paris); 2013 Dec; 74(5-6):487-90. PubMed ID: 23978337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in insulin therapy: a review of insulin degludec.
    King A
    J Fam Pract; 2012 May; 61(5 Suppl):S28-31. PubMed ID: 22577639
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer basal insulin analogues: degludec, detemir, glargine.
    Kalra S
    J Pak Med Assoc; 2013 Nov; 63(11):1442-4. PubMed ID: 24392539
    [No Abstract]   [Full Text] [Related]  

  • 14. Basal insulin analogues in the management of diabetes mellitus: What progress have we made?
    Owens DR; Matfin G; Monnier L
    Diabetes Metab Res Rev; 2014 Feb; 30(2):104-19. PubMed ID: 24026961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are the most recent basal insulins really the most innovative?].
    Laudo Pardos C; Puigdevall Gallego V
    Med Clin (Barc); 2016 Oct; 147(7):297-9. PubMed ID: 27369693
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin degludec for diabetes mellitus.
    Drug Ther Bull; 2013 Jul; 51(7):78-81. PubMed ID: 23842634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More from PHARMAC on long-acting insulin analogues: insulin glargine now funded.
    Moodie P
    N Z Med J; 2006 Jun; 119(1236):U2040. PubMed ID: 16807582
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin degludec: a long-acting modern insulin analogue with a predictable pharmacokinetic/pharmacodynamic profile.
    Rendell M
    Drugs Today (Barc); 2013 Jun; 49(6):387-97. PubMed ID: 23807942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin degludec + liraglutide (Xultophy°) in type 2 diabetes.
    Prescrire Int; 2017 May; 26(182):121. PubMed ID: 30730669
    [No Abstract]   [Full Text] [Related]  

  • 20. [New drugs for diabetes treatment. Fast-acting insulin analogues].
    Forst T
    Pharm Unserer Zeit; 2001; 30(2):118-23. PubMed ID: 11279981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.